REGN Regeneron Pharmaceuticals, Inc.

REGN Regeneron Pharmaceuticals, Inc.

Healthcare · Biotechnology

Market read

Scan convergence 1 scan as of 2026-08-14 1 bear converging

POC $754.73 · VWAP $677.28 · +19.0% vs 12m avg buyer

uptrend vol: compressedgaps: stablechurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

2 watchlists

Watchlists @biotech-scan@ibb

REGN Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist REGN belongs to, members best 30-day change first — REGN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@ibb
@biotech-scan

Next earnings REGN reports in 71 days Oct 28

Last report Apr 29

Reported the quarter ending 2026-03-31: revenue $3.61B, diluted EPS $6.75, net income $727M (SEC filing). Across the print the stock moved -3.4% (close before → first close after).

full note →

Against street estimates

How REGN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 30 · projection Aug 17

Result
Jul 30 10.2114.29+40.0%Beat
Apr 29 8.909.47 GAAP ≠ +6.4%Beat
Jan 30 10.7511.44+6.4%Beat
Oct 28 '25 9.6411.83+22.7%Beat
Aug 1 '25 8.4412.89+52.7%Beat
Apr 29 '25 8.488.22-3.0%Miss
Feb 4 '25 11.1912.07+7.8%Beat
Oct 31 '24 11.7012.46+6.5%Beat

News (last pull)

Headlines about REGN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 58 days ago · Jun 21 · last pull reported an error, so these may be older than they look

Types
Jul 30 Catalyst REGN earnings
Apr 29 Catalyst REGN earnings